Measurements and Main Results
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
- Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.Intensive Care Med. 2005; 31: 638-644
- Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.Int J Cardiol. 2016; 202: 138-143
- Levosimendan versus dobutamine in myocardial injury patients with septic shock: A randomized controlled trial.Med Sci Monit. 2016; 22: 1486-1896
- Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: Mechanism and clinical application.J Int Med Res. 2019; 47: 1817-1828
- Levosimendan for the prevention of acute organ dysfunction in sepsis.N Engl J Med. 2016; 375: 1638-1648
- Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: A subgroup analysis of the LeoPARDS randomised trial.Intensive Care Med. 2019; 45: 1392-1400
- Phenotyping heart failure according to the longitudinal ejection fraction change: Myocardial strain, predictors, and outcomes.J Am Heart Assoc. 2020; 9e015009
- Comparison of baseline versus posttreatment left ventricular ejection fraction in patients with acute decompensated heart failure for predicting cardiovascular outcome: Implications from single-center systolic heart failure cohort.PLoS One. 2016; 11e0145514
- Inotropic support during experimental endotoxemic shock: Part II. A comparison of levosimendan with dobutamine.Anesth Analg. 2009; 109: 1576-1583
- Levosimendan treatment of myocardial depression in sepsis: A case series and review of the literature.Medicana Interna De Mexico. 2010; 26: 324-336
- Effects of levosimendan on cellular metabolic alterations in patients with septic shock: A randomized controlled pilot study.Shock. 2017; 48: 307-312
- Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study.Crit Care. 2011; 15: R166
- Levosimendan mitigates coagulopathy and organ dysfunction in rats with endotoxemia.J Chin Med Assoc. 2017; 80: 432-441
- Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: Studies in a rat model.Crit Care. 2014; 18: 652-664
- The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.J Crit Care. 2017; 37: 91-98
- Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.J Crit Care. 2015; 30: 908-913
- Levosimendan plus dobutamine in acute decompensated heart failure refractory to dobutamine.J Clin Med. 2020; 9: 3605
Publication stageIn Press Corrected Proof
Funding for this paper was received from the Baoding Science and Technology Project (2041ZF314).
Tao Sun and Nan Zhang contributed equally to this article.